Overview


Hemodialysis access grafts play a crucial role in treating individuals with end-stage renal disease (ESRD), where the kidneys fail to perform their vital filtration functions. These grafts are artificial conduits, linking an artery and a vein, allowing for efficient blood flow during hemodialysis sessions. This procedure is a lifeline for many ESRD patients, as it facilitates the removal of waste products and excess fluids from the bloodstream, essentially performing the role of the impaired kidneys. The graft is typically constructed from synthetic materials, such as expanded polytetrafluoroethylene (ePTFE) or other biocompatible substances. This construction enables the graft to withstand the repeated needle punctures required for hemodialysis access. Surgical graft placement involves creating a direct connection between an artery and a vein, usually in the arm. This fusion, known as an arteriovenous graft, provides a stable access point for the hemodialysis machine.

Moreover, the lifespan of a hemodialysis access graft is finite, and over time, wear and tear can lead to decreased efficacy, requiring intervention. While arteriovenous fistulas (direct connections between an artery and a vein without the use of synthetic graft material) are considered the gold standard for vascular access in hemodialysis, access grafts are valuable alternatives for patients with vessels unsuitable for fistula creation.

FutureWise Market Research has published a report that provides an insightful analysis of Hemodialysis Access Graft Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Hemodialysis Access Graft Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • W.L. Gore & Associated
  • C. R. Bard
  • Merit Medical Systems, Inc.
  • Getinge Group.

(Note: The list of the major players will be updated with the latest market scenario and trends)

The increasing prevalence of CKD, often associated with diabetes and hypertension, drives the demand for hemodialysis access grafts. As the global population ages, kidney-related conditions and the need for dialysis access grafts are expected to rise. Ongoing developments in graft materials and surgical techniques are improving the performance and longevity of hemodialysis access grafts, thereby driving market growth. Higher healthcare spending, particularly in developed regions, allows for greater access to advanced treatments, including hemodialysis access grafts. Hemodialysis access grafts offer a less invasive alternative to other types of vascular access, which can be a significant driver for their adoption.

However, hemodialysis access grafts may be associated with complications such as thrombosis, stenosis, and infection, often requiring reinterventions and impacting patient outcomes. The lifespan of hemodialysis access grafts can be limited, leading to the need for replacement or additional interventions. Infection at the graft site is a significant concern, especially in immunocompromised patients, and can lead to severe complications. The cost associated with hemodialysis access graft procedures, including the initial implantation and potential reinterventions, can significantly influence their adoption.

By material

  • Biological Grafts
  • Synthetic Grafts
  • Biosynthetic Grafts

By End user

  • Hospitals
  • Dialysis centers
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the rising prevalence of non-communicable conditions like diabetes and hypertension, known precursors to chronic kidney diseases (CKDs), which is projected to boost the requirement for hematology vascular access grafts in this area. Additionally, North America is witnessing a surge in cases of renal diseases that often culminate in kidney failure. Moreover, the well-established regulatory framework and a growing preference for biological grafts are among the factors propelling market growth in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Hemodialysis Access Graft Market By Material, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Hemodialysis Access Graft Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Hemodialysis Access Graft Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Hemodialysis Access Graft Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Hemodialysis Access Graft Market, By Material Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Biological Grafts
      2. Synthetic Grafts
      3. Biosynthetic Grafts
  • 8.  Hemodialysis Access Graft Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Hospitals
      2. Dialysis centers
      3. Ambulatory Surgical Centers
      4. Clinics
      5. Home Care Settings
  • 9.  North America Hemodialysis Access Graft Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 10.  Latin America Hemodialysis Access Graft Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 11.  Europe Hemodialysis Access Graft Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 12.  Asia Pacific Hemodialysis Access Graft Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 13.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 14.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 15.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. W.L. Gore & Associated, 
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. C. R. Bard
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. Merit Medical Systems, Inc. 
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Getinge Group.
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview

  • 16.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11